The DOI matches its Crossref record.
Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226
Abstract
Prenatal testing for chromosomal abnormalities is designed to provide an accurate assessment of a patient’s risk of carrying a fetus with a chromosomal disorder. A wide variety of prenatal screening and diagnostic tests are available; each offers varying levels of information and performance, and each has relative advantages and limitations. When considering screening test characteristics, no one test is superior in all circumstances, which results in the need for nuanced, patient-centered counseling from the obstetric care professional and complex decision making by the patient. Each patient should be counseled in each pregnancy about options for testing for fetal chromosomal abnormalities. It is important that obstetric care professionals be prepared to discuss not only the risk of fetal chromosomal abnormalities but also the relative benefits and limitations of the available screening and diagnostic tests. Testing for chromosomal abnormalities should be an informed patient choice based on provision of adequate and accurate information, the patient’s clinical context, accessible health care resources, values, interests, and goals. All patients should be offered both screening and diagnostic tests, and all patients have the right to accept or decline testing after counseling. The purpose of this Practice Bulletin is to provide current information regarding the available screening test options available for fetal chromosomal abnormalities and to review their benefits, performance characteristics, and limitations. For information regarding prenatal diagnostic testing for genetic disorders, refer to Practice Bulletin No. 162, Prenatal Diagnostic Testing for Genetic Disorders. For additional information regarding counseling about genetic testing and communicating test results, refer to Committee Opinion No. 693, Counseling About Genetic Testing and Communication of Genetic Test Results. For information regarding carrier screening for genetic conditions, refer to Committee Opinion No. 690, Carrier Screening in the Age of Genomic Medicine, and Committee Opinion No. 691, Carrier Screening for Genetic Conditions. This Practice Bulletin has been revised to further clarify methods of screening for fetal chromosomal abnormalities, including expanded information regarding the use of cell-free DNA in all patients regardless of maternal age or baseline risk, and to add guidance related to patient counseling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Health Supervision for Children With Down Syndrome
Bull, M. J., & the Committee on Genetics (2011) · Pediatrics · doi:10.1542/peds.2011-1605 · Cited by 1,231
Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasma
Wang, E., Batey, A., Struble, C., Musci, T., Song, K., & Oliphant, A. (2013) · Prenatal Diagnosis · doi:10.1002/pd.4119 · Cited by 440
Sparks, A. B., Struble, C. A., Wang, E. T., Song, K., & Oliphant, A. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.01.030 · Cited by 395
Sehnert, A. J., Rhees, B., Comstock, D., de Feo, E., Heilek, G., Burke, J., & Rava, R. P. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165910 · Cited by 288
Obesity in Pregnancy: ACOG Practice Bulletin, Number 230
(2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004395 · Cited by 252
Metadata
- Venue
- Obstetrics & Gynecology
- Published
- 2020-10
- Volume
- 136
- Issue
- 4
- Pages
- 859-867
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W3084562374
- Cited by
- 385
- References
- 0
- FWCI
- 23.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226. https://app.cochat.ai/papers/10.1097/aog.0000000000004107
- The paper
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226. (2020). Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000004107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.